A new national study is highlighting disparities in morbidity and barriers to care that face patients with chronic obstructive pulmonary disease (COPD) living in in rural areas.
Previous research has indicated that where you live can have an impact on various aspects of your health, with people living in rural areas often being at a disadvantage. Now, a new national study is highlighting disparities in morbidity and barriers to care that face patients with chronic obstructive pulmonary disease (COPD) living in in these areas.
The study showed that the prevalence of COPD was 8.6% in rural counties and 5.4% in urban counties. Patients living in rural areas were more likely to be uninsured (12.6% vs 10.4%) and were 18% more likely to not visit a doctor because of the cost.
“Our findings have important policy implications,” argued the researchers, who wrote, “The challenge of improving health and health care for the US rural population—including for those with COPD—has led to a number of policy proposals, many of which focus on addressing the relative scarcity of providers. For instance, the expanded use of telehealth has been proposed as a solution to regional provider shortages, an approach embraced by the Trump administration.”
The more than 34,000 patients included in the study were identified through the 2019 Behavioral Risk Factor Surveillance System, 21,758 of which lived in urban counties and 12,681 of which lived in rural counties.
In rural counties, racial and ethnic minorities were the most likely to forgo care. While 17.6% of rural Whites had forgone a medical visit due to cost, 35.3% of Blacks, 38.1% of American Indians, and 34.3% of Hispanics had forgone a medical visit due to cost.
A look at patient characteristics showed that those living in rural counties were older, more likely to be White, be married, and be a daily smoker. They were also more likely to be unemployed and have lower incomes and lower levels of education.
Looking at health outcomes, patients living in rural areas reported:
The researchers emphasized that the findings also have particular implications for COVID-19, drawing on findings from a CDC analysis of 74,000 patients with COVID-19, which showed that those admitted to the intensive care unit for the virus had COPD or asthma. As hospitalization can accrue high out-of-pocket costs for those who are uninsured and underinsured, “Patients with COPD, and in particular those from rural areas, racial/ethnic minorities, and those of low income, may hence beat particular risk of financial toxicity due to medical costs during this pandemic,” they noted.
Reference
Gaffney A, Hawks L, White A, et al. Health care disparities across the urban-rural divide: a national study of individuals with COPD. J Rural Health. Published online October 11, 2020. doi:10.1111/jrh.12525.
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Read More
Updated mRNA Vaccines Against JN.1 Show Strong Safety Signal in Real-World Data
July 31st 2025A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and supporting continued use in high-risk populations amid ongoing viral evolution.
Read More
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More